

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 7.19366279 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 6.81342500 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.12180933 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.95175690 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.95175690 |
| 6 | viral transcription (GO:0019083) | 5.47908203 |
| 7 | protein prenylation (GO:0018342) | 5.44230398 |
| 8 | prenylation (GO:0097354) | 5.44230398 |
| 9 | ribosomal large subunit biogenesis (GO:0042273) | 5.33510276 |
| 10 | translational termination (GO:0006415) | 5.26182521 |
| 11 | cytochrome complex assembly (GO:0017004) | 5.07584890 |
| 12 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.91603393 |
| 13 | GTP biosynthetic process (GO:0006183) | 4.88438953 |
| 14 | translational elongation (GO:0006414) | 4.86694043 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.84672302 |
| 16 | valine metabolic process (GO:0006573) | 4.81662067 |
| 17 | respiratory chain complex IV assembly (GO:0008535) | 4.75787166 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 4.74236184 |
| 19 | protein targeting to ER (GO:0045047) | 4.73714318 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 4.59331346 |
| 21 | DNA deamination (GO:0045006) | 4.58754415 |
| 22 | ribosomal small subunit assembly (GO:0000028) | 4.55954088 |
| 23 | branched-chain amino acid catabolic process (GO:0009083) | 4.51919055 |
| 24 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.45444304 |
| 25 | respiratory electron transport chain (GO:0022904) | 4.42362274 |
| 26 | protein localization to endoplasmic reticulum (GO:0070972) | 4.39565767 |
| 27 | electron transport chain (GO:0022900) | 4.35449939 |
| 28 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.30193475 |
| 29 | amino acid salvage (GO:0043102) | 4.24919749 |
| 30 | L-methionine salvage (GO:0071267) | 4.24919749 |
| 31 | L-methionine biosynthetic process (GO:0071265) | 4.24919749 |
| 32 | UTP biosynthetic process (GO:0006228) | 4.21204254 |
| 33 | UTP metabolic process (GO:0046051) | 4.06939522 |
| 34 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.04438893 |
| 35 | protein complex biogenesis (GO:0070271) | 3.96814050 |
| 36 | cellular protein complex disassembly (GO:0043624) | 3.95731738 |
| 37 | translation (GO:0006412) | 3.90572948 |
| 38 | translational initiation (GO:0006413) | 3.88222323 |
| 39 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.88060208 |
| 40 | viral life cycle (GO:0019058) | 3.86479410 |
| 41 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.82823167 |
| 42 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.79539026 |
| 43 | maturation of 5.8S rRNA (GO:0000460) | 3.79514858 |
| 44 | maturation of SSU-rRNA (GO:0030490) | 3.79369596 |
| 45 | pseudouridine synthesis (GO:0001522) | 3.77123092 |
| 46 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.75679026 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.71889082 |
| 48 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.69331128 |
| 49 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.67214822 |
| 50 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.61713840 |
| 51 | seminiferous tubule development (GO:0072520) | 3.61385969 |
| 52 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.57875057 |
| 53 | rRNA modification (GO:0000154) | 3.56148998 |
| 54 | regulation of translation in response to stress (GO:0043555) | 3.52678163 |
| 55 | branched-chain amino acid metabolic process (GO:0009081) | 3.51799485 |
| 56 | proteasome assembly (GO:0043248) | 3.49547552 |
| 57 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.49519060 |
| 58 | ATP biosynthetic process (GO:0006754) | 3.49470814 |
| 59 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.47423079 |
| 60 | regulation of podosome assembly (GO:0071801) | 3.47012317 |
| 61 | cellular component biogenesis (GO:0044085) | 3.43370396 |
| 62 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.41833685 |
| 63 | mitochondrion transport along microtubule (GO:0047497) | 3.41833685 |
| 64 | methionine biosynthetic process (GO:0009086) | 3.39243316 |
| 65 | CTP biosynthetic process (GO:0006241) | 3.34522610 |
| 66 | CTP metabolic process (GO:0046036) | 3.34522610 |
| 67 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.31806485 |
| 68 | regulation of mitochondrial translation (GO:0070129) | 3.27540760 |
| 69 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.24505645 |
| 70 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.24305494 |
| 71 | cardiovascular system development (GO:0072358) | 3.22111755 |
| 72 | purine nucleotide salvage (GO:0032261) | 3.19683103 |
| 73 | rRNA methylation (GO:0031167) | 3.18725194 |
| 74 | cytokinetic process (GO:0032506) | 3.18440167 |
| 75 | hydrogen ion transmembrane transport (GO:1902600) | 3.16140529 |
| 76 | protein targeting to membrane (GO:0006612) | 3.14362712 |
| 77 | oxidative phosphorylation (GO:0006119) | 3.12838123 |
| 78 | protein complex disassembly (GO:0043241) | 3.11773473 |
| 79 | protein maturation by protein folding (GO:0022417) | 3.09874235 |
| 80 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.09071194 |
| 81 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05043475 |
| 82 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05043475 |
| 83 | protein targeting to mitochondrion (GO:0006626) | 3.02380248 |
| 84 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.02299859 |
| 85 | establishment of mitochondrion localization (GO:0051654) | 3.01743309 |
| 86 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.00232181 |
| 87 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.98338440 |
| 88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.96983699 |
| 89 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.96307378 |
| 90 | protein neddylation (GO:0045116) | 2.96088348 |
| 91 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.94515125 |
| 92 | negative regulation of membrane potential (GO:0045837) | 2.94194224 |
| 93 | mast cell degranulation (GO:0043303) | 2.92638817 |
| 94 | mast cell activation involved in immune response (GO:0002279) | 2.92638817 |
| 95 | proton transport (GO:0015992) | 2.91228149 |
| 96 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.90672118 |
| 97 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.90458339 |
| 98 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.90458339 |
| 99 | NADH dehydrogenase complex assembly (GO:0010257) | 2.90458339 |
| 100 | negative regulation of heart rate (GO:0010459) | 2.90221641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.36137427 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.35522169 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.64675341 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.29455047 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.10888418 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.08211934 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.27997611 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02434663 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.02087048 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.01181796 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.82472120 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.68761945 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.66497377 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.64182663 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.42160461 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.41556757 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.37824561 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.32361858 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28423760 |
| 20 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.27629829 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.21533294 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.20050560 |
| 23 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.18166054 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06931200 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.03079503 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.87558160 |
| 27 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.80718344 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78609361 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77566586 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77170253 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73089141 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.67482485 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.63818515 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.58429872 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57216509 |
| 36 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53012827 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52176557 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.51285143 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.48279571 |
| 40 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.48220205 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.43176596 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40778531 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39445281 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38792364 |
| 45 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38752857 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29501782 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25443191 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24937261 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23010218 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22705560 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21700332 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20497052 |
| 53 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.19679611 |
| 54 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16330362 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15465617 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14666259 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14267328 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13776050 |
| 59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12211796 |
| 60 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10304472 |
| 61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10303718 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10280949 |
| 63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09679247 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08108931 |
| 65 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05020026 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.03034895 |
| 67 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02938757 |
| 68 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01301888 |
| 69 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00091424 |
| 70 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98859657 |
| 71 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97155041 |
| 72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96332137 |
| 73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96332137 |
| 74 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95881579 |
| 75 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95712553 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94727652 |
| 77 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94072614 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91677005 |
| 79 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90536310 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90345533 |
| 81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89761414 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.89457125 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88725492 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88725492 |
| 85 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.87768056 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87711371 |
| 87 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86690026 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86637873 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84011826 |
| 90 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.82855854 |
| 91 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82357432 |
| 92 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81235036 |
| 93 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.80395076 |
| 94 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.79958873 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79583484 |
| 96 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.77732276 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.77224777 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77167749 |
| 99 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77164979 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76987633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 8.28258810 |
| 2 | MP0005671_abnormal_response_to | 3.87749079 |
| 3 | MP0003646_muscle_fatigue | 3.72378786 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 2.93393608 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.93393608 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 2.50702834 |
| 7 | MP0001873_stomach_inflammation | 2.39157554 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.36528336 |
| 9 | MP0004858_abnormal_nervous_system | 2.19944584 |
| 10 | MP0002163_abnormal_gland_morphology | 2.19271621 |
| 11 | MP0008058_abnormal_DNA_repair | 2.01933378 |
| 12 | MP0000685_abnormal_immune_system | 1.88558614 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 1.88160260 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84905497 |
| 15 | MP0003880_abnormal_central_pattern | 1.83661493 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 1.81552603 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 1.73905582 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 1.70311261 |
| 19 | MP0005503_abnormal_tendon_morphology | 1.60715227 |
| 20 | MP0001790_abnormal_immune_system | 1.59488741 |
| 21 | MP0005387_immune_system_phenotype | 1.59488741 |
| 22 | MP0001529_abnormal_vocalization | 1.59471058 |
| 23 | MP0002102_abnormal_ear_morphology | 1.58735281 |
| 24 | MP0002095_abnormal_skin_pigmentation | 1.54542431 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.53554145 |
| 26 | MP0009785_altered_susceptibility_to | 1.53514809 |
| 27 | MP0008872_abnormal_physiological_respon | 1.52599274 |
| 28 | MP0003693_abnormal_embryo_hatching | 1.52243080 |
| 29 | MP0001800_abnormal_humoral_immune | 1.50316886 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.48088442 |
| 31 | MP0001919_abnormal_reproductive_system | 1.46577633 |
| 32 | MP0003718_maternal_effect | 1.39869543 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.38345058 |
| 34 | MP0003195_calcinosis | 1.37095438 |
| 35 | MP0003011_delayed_dark_adaptation | 1.35659579 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.35406318 |
| 37 | MP0005360_urolithiasis | 1.32359723 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.29566741 |
| 39 | MP0005389_reproductive_system_phenotype | 1.25441943 |
| 40 | MP0003724_increased_susceptibility_to | 1.24838199 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.24811404 |
| 42 | MP0003866_abnormal_defecation | 1.22398569 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.19103159 |
| 44 | MP0004957_abnormal_blastocyst_morpholog | 1.13077883 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.12809666 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.12746476 |
| 47 | MP0001853_heart_inflammation | 1.10258013 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.10197605 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.08929912 |
| 50 | MP0002723_abnormal_immune_serum | 1.08360917 |
| 51 | MP0006082_CNS_inflammation | 1.06711354 |
| 52 | MP0003186_abnormal_redox_activity | 1.06217240 |
| 53 | MP0002736_abnormal_nociception_after | 1.04941939 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.04880136 |
| 55 | MP0001663_abnormal_digestive_system | 1.02399523 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.02294232 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.00216419 |
| 58 | MP0002132_abnormal_respiratory_system | 0.99993775 |
| 59 | MP0005025_abnormal_response_to | 0.98937485 |
| 60 | MP0003786_premature_aging | 0.98121547 |
| 61 | MP0002160_abnormal_reproductive_system | 0.97569583 |
| 62 | MP0001819_abnormal_immune_cell | 0.96747583 |
| 63 | MP0002452_abnormal_antigen_presenting | 0.95039806 |
| 64 | MP0000569_abnormal_digit_pigmentation | 0.92836155 |
| 65 | MP0005410_abnormal_fertilization | 0.91479161 |
| 66 | MP0004885_abnormal_endolymph | 0.86051973 |
| 67 | MP0005174_abnormal_tail_pigmentation | 0.85947757 |
| 68 | MP0002938_white_spotting | 0.85734796 |
| 69 | MP0005499_abnormal_olfactory_system | 0.84800042 |
| 70 | MP0005394_taste/olfaction_phenotype | 0.84800042 |
| 71 | MP0004147_increased_porphyrin_level | 0.84577725 |
| 72 | MP0000049_abnormal_middle_ear | 0.83891732 |
| 73 | MP0005332_abnormal_amino_acid | 0.80219347 |
| 74 | MP0001845_abnormal_inflammatory_respons | 0.79482700 |
| 75 | MP0000858_altered_metastatic_potential | 0.75689773 |
| 76 | MP0008995_early_reproductive_senescence | 0.75533304 |
| 77 | MP0000716_abnormal_immune_system | 0.73923265 |
| 78 | MP0008932_abnormal_embryonic_tissue | 0.73162326 |
| 79 | MP0002398_abnormal_bone_marrow | 0.72626135 |
| 80 | MP0001905_abnormal_dopamine_level | 0.72102278 |
| 81 | MP0000372_irregular_coat_pigmentation | 0.71082890 |
| 82 | MP0009046_muscle_twitch | 0.69010919 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.68657626 |
| 84 | MP0001119_abnormal_female_reproductive | 0.67822278 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.65255635 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.64925515 |
| 87 | MP0001968_abnormal_touch/_nociception | 0.64842790 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.64519347 |
| 89 | MP0002210_abnormal_sex_determination | 0.64259565 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.63202281 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.63079318 |
| 92 | MP0003878_abnormal_ear_physiology | 0.63079318 |
| 93 | MP0005670_abnormal_white_adipose | 0.62274002 |
| 94 | MP0002429_abnormal_blood_cell | 0.62087093 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.61869830 |
| 96 | MP0001756_abnormal_urination | 0.60909965 |
| 97 | MP0005395_other_phenotype | 0.59751535 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.59625149 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.59326070 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.59295901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.85994723 |
| 2 | Decreased central vision (HP:0007663) | 5.55743198 |
| 3 | Pendular nystagmus (HP:0012043) | 5.52338352 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.64618023 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.53505148 |
| 6 | Acanthocytosis (HP:0001927) | 4.48285851 |
| 7 | Disinhibition (HP:0000734) | 4.32436637 |
| 8 | Mitochondrial inheritance (HP:0001427) | 4.19152173 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.10660418 |
| 10 | Cerebral hypomyelination (HP:0006808) | 4.07705669 |
| 11 | Self-mutilation (HP:0000742) | 4.07371225 |
| 12 | Increased CSF lactate (HP:0002490) | 4.03142689 |
| 13 | Personality changes (HP:0000751) | 3.86239272 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.85393772 |
| 15 | Acute encephalopathy (HP:0006846) | 3.78693613 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.64977644 |
| 17 | Acute hepatic failure (HP:0006554) | 3.57889344 |
| 18 | Attenuation of retinal blood vessels (HP:0007843) | 3.53802490 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.49713889 |
| 20 | Abnormality of alanine metabolism (HP:0010916) | 3.29209629 |
| 21 | Hyperalaninemia (HP:0003348) | 3.29209629 |
| 22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.29209629 |
| 23 | Keratoconus (HP:0000563) | 3.28934862 |
| 24 | Increased corneal curvature (HP:0100692) | 3.28934862 |
| 25 | Hepatic necrosis (HP:0002605) | 3.23198195 |
| 26 | Cerebral edema (HP:0002181) | 3.19668218 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 3.15110737 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07587730 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07587730 |
| 30 | Aplastic anemia (HP:0001915) | 3.06752668 |
| 31 | Increased serum lactate (HP:0002151) | 2.99464522 |
| 32 | Optic disc pallor (HP:0000543) | 2.97002083 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 2.96049868 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 2.87515756 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.82474564 |
| 36 | Exertional dyspnea (HP:0002875) | 2.82074696 |
| 37 | Dyskinesia (HP:0100660) | 2.75393138 |
| 38 | Inappropriate behavior (HP:0000719) | 2.62423637 |
| 39 | Carpal bone hypoplasia (HP:0001498) | 2.60571848 |
| 40 | Hypothermia (HP:0002045) | 2.60526933 |
| 41 | Lactic acidosis (HP:0003128) | 2.58244505 |
| 42 | Stomatitis (HP:0010280) | 2.54813442 |
| 43 | Macrocytic anemia (HP:0001972) | 2.52927225 |
| 44 | CNS hypomyelination (HP:0003429) | 2.47708467 |
| 45 | Pallor (HP:0000980) | 2.47072146 |
| 46 | IgG deficiency (HP:0004315) | 2.42238731 |
| 47 | Unsteady gait (HP:0002317) | 2.41218146 |
| 48 | Respiratory failure (HP:0002878) | 2.39350625 |
| 49 | CNS demyelination (HP:0007305) | 2.37160823 |
| 50 | Respiratory difficulties (HP:0002880) | 2.36455786 |
| 51 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34419150 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33789411 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.28967880 |
| 54 | Hyperphosphaturia (HP:0003109) | 2.28387255 |
| 55 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.21842262 |
| 56 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.21842262 |
| 57 | Agitation (HP:0000713) | 2.19600677 |
| 58 | Choreoathetosis (HP:0001266) | 2.18640768 |
| 59 | Irregular epiphyses (HP:0010582) | 2.16028016 |
| 60 | Lethargy (HP:0001254) | 2.12878500 |
| 61 | Abnormal number of erythroid precursors (HP:0012131) | 2.12556091 |
| 62 | Chronic bronchitis (HP:0004469) | 2.11738558 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.06136146 |
| 64 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04920504 |
| 65 | Congenital stationary night blindness (HP:0007642) | 2.03460157 |
| 66 | Exercise intolerance (HP:0003546) | 2.00417978 |
| 67 | Microretrognathia (HP:0000308) | 1.99052210 |
| 68 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97674944 |
| 69 | Premature ovarian failure (HP:0008209) | 1.96753087 |
| 70 | Cleft eyelid (HP:0000625) | 1.96136138 |
| 71 | Leukodystrophy (HP:0002415) | 1.95301434 |
| 72 | Abnormal albumin level (HP:0012116) | 1.93370983 |
| 73 | Hypoalbuminemia (HP:0003073) | 1.93370983 |
| 74 | Emotional lability (HP:0000712) | 1.93056336 |
| 75 | Constricted visual fields (HP:0001133) | 1.89299406 |
| 76 | Limb hypertonia (HP:0002509) | 1.88887097 |
| 77 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84831655 |
| 78 | Macular degeneration (HP:0000608) | 1.84302979 |
| 79 | Reticulocytopenia (HP:0001896) | 1.78684390 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 1.77801632 |
| 81 | Abnormality of renal resorption (HP:0011038) | 1.77765882 |
| 82 | Type II lissencephaly (HP:0007260) | 1.75073162 |
| 83 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.74491793 |
| 84 | Oligomenorrhea (HP:0000876) | 1.73988230 |
| 85 | Progressive microcephaly (HP:0000253) | 1.73285596 |
| 86 | Secondary amenorrhea (HP:0000869) | 1.71035985 |
| 87 | Psychosis (HP:0000709) | 1.70893999 |
| 88 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.70470237 |
| 89 | Poikilocytosis (HP:0004447) | 1.69823465 |
| 90 | Generalized aminoaciduria (HP:0002909) | 1.67861995 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 1.67252247 |
| 92 | Severe muscular hypotonia (HP:0006829) | 1.67115427 |
| 93 | Muscle fiber atrophy (HP:0100295) | 1.66501401 |
| 94 | Rectal fistula (HP:0100590) | 1.64903355 |
| 95 | Rectovaginal fistula (HP:0000143) | 1.64903355 |
| 96 | Vasculitis (HP:0002633) | 1.64205221 |
| 97 | Hypoproteinemia (HP:0003075) | 1.60193587 |
| 98 | Memory impairment (HP:0002354) | 1.58607193 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 1.57698974 |
| 100 | Glycosuria (HP:0003076) | 1.57698974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 6.59779431 |
| 2 | BMPR2 | 4.97840311 |
| 3 | MUSK | 4.05064282 |
| 4 | BCKDK | 3.30005573 |
| 5 | TXK | 2.78903134 |
| 6 | RIPK4 | 2.75633459 |
| 7 | VRK2 | 2.60954647 |
| 8 | CDK19 | 2.45964397 |
| 9 | GRK1 | 2.37665284 |
| 10 | NUAK1 | 2.37151735 |
| 11 | TIE1 | 2.31575017 |
| 12 | MAP4K1 | 2.30166855 |
| 13 | TLK1 | 1.99194616 |
| 14 | KDR | 1.98161883 |
| 15 | MST4 | 1.92707221 |
| 16 | WNK3 | 1.91521399 |
| 17 | BUB1 | 1.81054628 |
| 18 | ADRBK2 | 1.54583683 |
| 19 | PDK2 | 1.51824549 |
| 20 | TAOK3 | 1.47208041 |
| 21 | ZAK | 1.44975613 |
| 22 | VRK1 | 1.25245852 |
| 23 | NME1 | 1.18554655 |
| 24 | IKBKB | 1.10412898 |
| 25 | EPHA3 | 1.07867176 |
| 26 | CDC7 | 1.07187948 |
| 27 | LRRK2 | 1.05331291 |
| 28 | PBK | 1.04644291 |
| 29 | TSSK6 | 1.04596527 |
| 30 | DYRK2 | 1.02716795 |
| 31 | OXSR1 | 1.01367154 |
| 32 | ITK | 0.95732698 |
| 33 | PIK3CG | 0.93775698 |
| 34 | INSRR | 0.88736025 |
| 35 | RPS6KA5 | 0.86715563 |
| 36 | PLK4 | 0.85857324 |
| 37 | MYLK | 0.79612198 |
| 38 | TEC | 0.78637267 |
| 39 | FRK | 0.76390550 |
| 40 | CDK4 | 0.73257833 |
| 41 | OBSCN | 0.70657571 |
| 42 | LCK | 0.69857244 |
| 43 | GRK6 | 0.69683382 |
| 44 | WNK4 | 0.69325735 |
| 45 | BTK | 0.68395605 |
| 46 | ACVR1B | 0.67682208 |
| 47 | DAPK1 | 0.67555344 |
| 48 | CSNK2A1 | 0.65797316 |
| 49 | CSK | 0.65134565 |
| 50 | SYK | 0.65013043 |
| 51 | FES | 0.62966881 |
| 52 | MAP4K2 | 0.62879949 |
| 53 | GRK5 | 0.61124806 |
| 54 | JAK3 | 0.60514147 |
| 55 | BMPR1B | 0.57995295 |
| 56 | PRKCG | 0.55890141 |
| 57 | MAP3K13 | 0.55886484 |
| 58 | CSNK2A2 | 0.54544236 |
| 59 | MAP3K9 | 0.52911313 |
| 60 | GRK7 | 0.50489388 |
| 61 | PRKACA | 0.50412658 |
| 62 | PLK3 | 0.49585972 |
| 63 | KIT | 0.48652276 |
| 64 | ADRBK1 | 0.45492160 |
| 65 | ABL2 | 0.45457442 |
| 66 | PASK | 0.44340900 |
| 67 | ARAF | 0.43819658 |
| 68 | PIM2 | 0.43212314 |
| 69 | AURKA | 0.41306073 |
| 70 | PLK1 | 0.41157196 |
| 71 | TGFBR1 | 0.41057002 |
| 72 | CSF1R | 0.41056705 |
| 73 | MAP3K4 | 0.40891613 |
| 74 | TAF1 | 0.40064542 |
| 75 | AURKB | 0.39777763 |
| 76 | ILK | 0.39294206 |
| 77 | MAP3K12 | 0.37049580 |
| 78 | PRKCA | 0.36067258 |
| 79 | PRKCB | 0.35800394 |
| 80 | IKBKE | 0.35616061 |
| 81 | TESK2 | 0.35506939 |
| 82 | CDK8 | 0.34047622 |
| 83 | ALK | 0.33242652 |
| 84 | PHKG1 | 0.32577086 |
| 85 | PHKG2 | 0.32577086 |
| 86 | NEK1 | 0.31613739 |
| 87 | DAPK3 | 0.29598676 |
| 88 | PRKCQ | 0.29260001 |
| 89 | PRKG1 | 0.27593175 |
| 90 | PRKACG | 0.27531535 |
| 91 | SRPK1 | 0.26666726 |
| 92 | CAMK2A | 0.25995330 |
| 93 | STK11 | 0.25916348 |
| 94 | PIM1 | 0.25898657 |
| 95 | CDK7 | 0.25457490 |
| 96 | MAPKAPK5 | 0.25356246 |
| 97 | PRKCI | 0.25056188 |
| 98 | MOS | 0.24537985 |
| 99 | RPS6KA4 | 0.24375844 |
| 100 | CHEK2 | 0.23634174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.02468892 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.15807902 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.93787079 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.27793698 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.25210340 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.23926907 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.22169003 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.04049047 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.34003396 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.27813258 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.20731677 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.19821310 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.19087618 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02975086 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.01198261 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91984344 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.86257259 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.81839091 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66308489 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.65460762 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.63342465 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59447697 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.58203410 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55652003 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52820293 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52324936 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44259663 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.32290518 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30812063 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.12894775 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09921504 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08797780 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07978652 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07729831 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 1.06558565 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98559958 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 0.96432270 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96190763 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92017739 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89942226 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84904005 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81700886 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.80393776 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 0.78922283 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 0.78003688 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77852179 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74317757 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68068049 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66694443 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65965242 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65507802 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64827565 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62547137 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60536363 |
| 55 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58736060 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58107737 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56975877 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56437508 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56189143 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 0.55762841 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52019450 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48181189 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47955613 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47919592 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47096413 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47060604 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44317519 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39546972 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37425743 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37355914 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36641406 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35177543 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34372247 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32288116 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31777739 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31386531 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31253315 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30856385 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30212811 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.29408436 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29316039 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.28904473 |
| 83 | Mismatch repair_Homo sapiens_hsa03430 | 0.27262227 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26553418 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25446493 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.24046203 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22886255 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.22679020 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21747236 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.21298768 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.16671415 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.15702196 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.14330925 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13934535 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.13912868 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13638814 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.12351368 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.12284652 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11676778 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.11079098 |

